Helsinki:ORNBV

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

July 21, 2025 03:30 ET  | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST           Darolutamide…

3 weeks ago